Form 4: Mycotopia Therapies Director Acquires 10 Million Shares in Lieu of Cash Compensation

Mycotopia Therapies director, Mark Croskery, acquired 10 million shares of common stock in lieu of cash compensation for director's fees.

Summary

• Mark Croskery, a director at Mycotopia Therapies, Inc., acquired 10,000,000 shares of common stock on December 13, 2024.
• The shares were acquired at a price of $0.014 per share.
• This acquisition was made in lieu of cash payment for a portion of the director's fees.
• Following this transaction, Mr. Croskery beneficially owns 10,016,912 shares of Mycotopia Therapies common stock.

Sentiment

Score: 6

Explanation: The transaction is neutral to slightly positive as it shows director confidence but could also indicate cash constraints.

Positives

• The acquisition of shares by a director demonstrates confidence in the company's future.
• The use of shares in lieu of cash may preserve the company's cash reserves.

Risks

• The acquisition of a large number of shares by a director could potentially lead to increased volatility in the stock price.
• The use of shares instead of cash compensation may indicate the company is facing cash flow constraints.

Management Comments

• The shares were received in lieu of cash for a portion of the filer's director's fees.

Industry Context

This type of transaction is common in publicly traded companies, where directors may receive stock as part of their compensation package. It aligns the director's interests with those of the shareholders.

Comparison to Industry Standards

• Many companies use stock-based compensation for directors to conserve cash and align interests.
• The specific amount and price of the shares are unique to Mycotopia Therapies and its compensation structure.
• Other companies in the biotech or pharmaceutical sector may use similar compensation methods, but the details will vary.

Stakeholder Impact

• Shareholders may view this as a positive sign of director commitment.
• The company may benefit from preserving cash by using stock for compensation.

Key Dates

Keywords

Mycotopia Therapies, Director, Share Acquisition, Common Stock, Form 4, Insider Trading, Compensation, Director Fees